PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAcyclovir
Acyclovir
Acyclovir, Sitavig, Xerese, Zovirax (acyclovir) is a small molecule pharmaceutical. Acyclovir was first approved as Zovirax on 1982-03-29. It is used to treat aids-related opportunistic infections, chickenpox, epstein-barr virus infections, herpes genitalis, and herpes labialis amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
stomatognathic diseasesD009057
nervous system diseasesD009422
eye diseasesD005128
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
immune system diseasesD007154
Trade Name
FDA
EMA
Acyclovir, Zovirax (discontinued: Acyclovir, Avaclyr, Zovirax)
Combinations
Xerese
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Acyclovir
Tradename
Company
Number
Date
Products
ZOVIRAXBausch Health CompaniesN-018604 RX1982-03-29
1 products, RLD, RS
ZOVIRAXBausch Health CompaniesN-021478 RX2002-12-30
1 products, RLD
Show 4 discontinued
Acyclovir sodium
Tradename
Company
Number
Date
Products
ZOVIRAXGSKN-018603 DISCN1982-10-22
3 products, RLD
Hide discontinued
Acyclovir
+
Hydrocortisone
Tradename
Company
Number
Date
Products
XERESEBausch Health CompaniesN-022436 RX2009-07-31
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
acyclovirANDA2025-02-10
acyclovir sodiumANDA2024-10-04
acyclovir suspensionANDA2023-11-03
acyclovir valacyclovir valacyclovir hydrochlorideANDA2023-06-29
acyclovixANDA2020-09-21
averteaxOTC monograph not final2014-03-08
jet-avert motion sickness aidC2002632023-12-15
lornameadOTC monograph final2013-03-06
lypsyl honeyberryOTC monograph final2018-12-27
lypsyl vanilla plumOTC monograph not final2013-12-13
Show 6 more
Agency Specific
FDA
EMA
Expiration
Code
ACYCLOVIR, AVACLYR, FERA PHARMS LLC
2026-03-29ODE-235
ACYCLOVIR, ACYCLOVIR, ALEMBIC
2024-06-12CGT
Patent Expiration
Patent
Expires
Flag
FDA Information
Acyclovir, Sitavig, Lnhc
85924342030-06-16DPU-1460
87478962027-06-03DPU-1460
87911272027-03-23DPU-1460
ATC Codes
D: Dermatologicals
D06: Antibiotics and chemotherapeutics for dermatological use
D06B: Chemotherapeutics for topical use
D06BB: Antivirals, topical
D06BB03: Aciclovir
D06BB53: Aciclovir, combinations
J: Antiinfectives for systemic use
J05: Antivirals for systemic use
J05A: Direct acting antivirals
J05AB: Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB01: Aciclovir
S: Sensory organ drugs
S01: Ophthalmologicals
S01A: Antiinfective ophthalmologics
S01AD: Antivirals, ophthalmologic
S01AD03: Aciclovir
HCPCS
Code
Description
J0133
Injection, acyclovir, 5 mg
Clinical
No data
Drug
General
Drug common nameAcyclovir
INNaciclovir
Description
Aciclovir, also known as acyclovir, is an antiviral medication. It is primarily used for the treatment of herpes simplex virus infections, chickenpox, and shingles. Other uses include prevention of cytomegalovirus infections following transplant and severe complications of Epstein–Barr virus infection. It can be taken by mouth, applied as a cream, or injected.
Classification
Small molecule
Drug classantivirals: antivirals (acyclovir type)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Nc1nc2c(ncn2COCCO)c(=O)[nH]1
Identifiers
PDB
CAS-ID59277-89-3
RxCUI
ChEMBL IDCHEMBL184
ChEBI ID2453
PubChem CID2022
DrugBankDB00787
UNII IDX4HES1O11F (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Acyclovir
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use